You are here
- Home
- Therapy Areas
- Oncology/Infection
An Open-label, phase I rising multiple dose, single-centre study to determine the PK & tolerabilityof ZD6474 at different dose levels in Chinese patients with solid malignancy tumor.
- Disease
- solid tumour
- Drug Name
- Caprelsa
- Generic Name
- vandetanib
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- Sep 26, 2006
- Study Name
- D4200L00004
- Study Id
- D4200L00004
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
